|

A Telehealth Advance Care Planning Intervention

RECRUITINGN/ASponsored by University of Rochester
Actively Recruiting
PhaseN/A
SponsorUniversity of Rochester
Started2024-05-20
Est. completion2027-09-30
Eligibility
Age60 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05875805

Summary

The objective of this project is to conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program on healthcare communication, patient anxiety and distress, as well as completion of advance directives (specifically MOLST and healthcare proxy forms) for older patients with acute myeloid leukemia, myelodysplastic syndrome, and similar myeloid malignancies.

Eligibility

Age: 60 Years+Healthy volunteers accepted
Inclusion and Exclusion Criteria for Patients

Inclusion criteria:

* Age ≥60 years
* A diagnosis of AML, MDS, and similar myeloid malignancies (including but not limited to MDS/MPN overlap syndrome, myelofibrosis)
* Being managed in the outpatient settings
* Able to provide informed consent
* English-speaking

Exclusion criteria:

\- None

Inclusion and Exclusion Criteria for Caregivers

Inclusion criteria:

* Age ≥18 years
* Selected by patient when asked if there is a "family member, partner, friend, or caregiver with whom you discuss or who can be helpful in health-related matters"
* Able to provide informed consent
* English-speaking

Exclusion criteria:

\- None

Inclusion and Exclusion Criteria for Oncology Providers

Inclusion criteria:

\- Oncologists and/or APPs who will be conducting the telehealth-delivered ACP visit

Exclusion criteria:

\- None

Conditions6

Acute Myeloid LeukemiaCancerMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmMyelofibrosisMyeloid Malignancy

Locations1 site

University of Rochester
Rochester, New York, 14642
Kah Poh Loh, MD585-276-4353kahpoh_loh@urmc.rochester.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.